Acute heart failure with accompanying chronic obstructive pulmonary disease. Should we focus on beta blockers?

Herz

Volumn 37, Issue 7, 2012, Pages 796-800

  Ege, M R ^a   Guray, U ^b   Guray, Y ^b   Yilmaz, M B ^c   Yucel, O ^c   Zorlu, A ^c   Tandogan, I ^c  

^a Kavaklidere Umut Hospital   (Turkey)

^b Yuksek Ihtisas Education and Research Hospital   (Turkey)

^c CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Acute heart failure; Beta blockers; Chronic obstructive pulmonary disease; Systolic heart failure

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; INOTROPIC AGENT; LOOP DIURETIC AGENT; METOPROLOL;

ACUTE HEART FAILURE; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 84872223303     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3641-x     Document Type: Article

References (20)

1. Ezekowitz JA, Hernandez AF, Starling RC et al (2009) Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J 157:219-228
2. Chung AK, Pang PS, Fonarow GC, Gheorghiade M (2008) Acute heart failure syndromes: potential strategies to improve post-discharge outcomes. Curr Treat Options Cardiovasc Med 10:349-357
3. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-989
4. Jondeau G, Neuder Y, Eicher JC et al (2009) B-CONVINCED: Beta-blocker continuation vs. interruption in patients with congestive heart failure hospitalized for a decompensation episode. Eur Heart J 30:2186-2192
5. Yilmaz MB, Laribi S, Mebazaa A (2010) Managing beta-blockers in acute heart failure: when to start and when to stop? Curr Heart Fail Rep 7:110-115
6. Peterson PN, Rumsfeld JS, Liang L et al (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3:25-32
7. De Blois J, Simard S, Atar D, Agewall S (2010) COPD predicts mortality in HF: the Norwegian heart failure registry. J Card Fail 16:225-229
8. Yilmaz MB, Refiker M, Guray Y et al (2007) Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life? Int J Clin Pract 61:225-230
9. Yilmaz MB, Refiker M (2007) Beta blockers in systolic heart failure: do physicians need more courage? Am Heart J 154:e23
10. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165-1185
11. Minas M, Dimitropoulos K, Pastaka C et al (2005) Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: gold opportunity for lung disorders. Prev Med 40:274-277
12. Lang RM, Bierig M, Devereux RB et al (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79-108
13. Nieminen MS, Bohm M, Cowie MR et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26:384-416
14. Iversen KK, Kjaergaard J, Akkan D et al (2008) Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 264:361-369
15. Gattis WA, O'Connor CM, Gallup DS et al (2004) Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43:1534-1541
16. Fonarow GC, Abraham WT, Albert NM et al (2008) Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 52:190-199
17. Butler J, Young JB, Abraham WT et al (2006) Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 47:2462-2469
18. Komajda M, Follath F, Swedberg K et al (2003) The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464-474
19. Shelton RJ, Rigby AS, Cleland JG, Clark AL (2006) Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure. Heart 92:331-336
20. Sueta CA, Bertoni AG, Massing MW et al (2005) Managed care patients with heart failure: spectrum of ventricular dysfunction and predictors of medication utilization. J Card Fail 11:106-111